Sherwin-Williams (NYSE:SHW) PT Raised to $390.00 at Citigroup

Sherwin-Williams (NYSE:SHW - Get Free Report) had its price objective hoisted by investment analysts at Citigroup from $360.00 to $390.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has a "buy" rating on the specialty chemicals company's stock. Citigroup's price objective would suggest a potential upside of 21.51% from the company's current price.

Several other equities analysts have also weighed in on the stock. JPMorgan Chase & Co. raised their price objective on shares of Sherwin-Williams from $285.00 to $317.00 and gave the company an "overweight" rating in a research report on Friday, January 26th. Argus increased their price objective on Sherwin-Williams from $330.00 to $378.00 and gave the stock a "buy" rating in a report on Thursday, December 21st. Barclays boosted their target price on shares of Sherwin-Williams from $285.00 to $315.00 and gave the stock an "equal weight" rating in a research report on Monday, January 29th. Robert W. Baird reissued a "neutral" rating and set a $300.00 price objective (up previously from $270.00) on shares of Sherwin-Williams in a report on Wednesday, January 3rd. Finally, The Goldman Sachs Group upped their price target on shares of Sherwin-Williams from $295.00 to $335.00 and gave the company a "buy" rating in a report on Thursday, December 14th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $326.50.

Sherwin-Williams Stock Down 4.1 %

Shares of SHW stock traded down $13.59 during trading hours on Wednesday, hitting $320.96. 1,563,108 shares of the company were exchanged, compared to its average volume of 1,399,602. The company has a debt-to-equity ratio of 2.25, a quick ratio of 0.48 and a current ratio of 0.83. The stock has a market capitalization of $81.67 billion, a price-to-earnings ratio of 35.00, a P/E/G ratio of 2.46 and a beta of 1.15. Sherwin-Williams has a one year low of $221.76 and a one year high of $348.37. The business's 50-day simple moving average is $327.78 and its two-hundred day simple moving average is $294.64.

Sherwin-Williams (NYSE:SHW - Get Free Report) last issued its quarterly earnings data on Thursday, January 25th. The specialty chemicals company reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.80 by $0.01. The firm had revenue of $5.25 billion during the quarter, compared to the consensus estimate of $5.23 billion. Sherwin-Williams had a return on equity of 74.72% and a net margin of 10.36%. The firm's revenue was up .4% on a year-over-year basis. During the same period in the prior year, the business earned $1.89 EPS. Sell-side analysts predict that Sherwin-Williams will post 11.44 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider Justin T. Binns sold 1,563 shares of the stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $338.87, for a total transaction of $529,653.81. Following the completion of the sale, the insider now directly owns 14,564 shares of the company's stock, valued at approximately $4,935,302.68. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, insider Todd D. Rea sold 2,449 shares of the stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $313.54, for a total transaction of $767,859.46. Following the completion of the transaction, the insider now directly owns 9,329 shares in the company, valued at approximately $2,925,014.66. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Justin T. Binns sold 1,563 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $338.87, for a total value of $529,653.81. Following the transaction, the insider now directly owns 14,564 shares of the company's stock, valued at $4,935,302.68. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,050 shares of company stock worth $10,340,237. Company insiders own 0.60% of the company's stock.

Hedge Funds Weigh In On Sherwin-Williams

A number of institutional investors have recently bought and sold shares of SHW. Norges Bank bought a new stake in shares of Sherwin-Williams during the 4th quarter worth about $1,176,356,000. FMR LLC increased its stake in shares of Sherwin-Williams by 65.4% during the third quarter. FMR LLC now owns 5,427,014 shares of the specialty chemicals company's stock worth $1,384,160,000 after purchasing an additional 2,146,102 shares during the period. Morgan Stanley boosted its stake in Sherwin-Williams by 50.9% in the 4th quarter. Morgan Stanley now owns 5,180,068 shares of the specialty chemicals company's stock valued at $1,229,386,000 after purchasing an additional 1,747,586 shares during the period. Alphinity Investment Management Pty Ltd acquired a new position in Sherwin-Williams in the 4th quarter valued at $432,737,000. Finally, Capital World Investors increased its position in Sherwin-Williams by 38.9% during the 4th quarter. Capital World Investors now owns 3,840,789 shares of the specialty chemicals company's stock worth $1,197,952,000 after buying an additional 1,075,351 shares during the period. Institutional investors and hedge funds own 77.67% of the company's stock.

About Sherwin-Williams

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.